Club Top 10 to Watch Monday, November 17th
1. Stock futures are fairly stable this morning. After a turbulent week, there’s some uncertainty regarding whether AI spending can hold up and if a rate cut in December is still likely.
2. Morgan Stanley has downgraded Dell’s rating by two levels to sell, expressing concerns about how a potential memory price supercycle could impact profit margins. At the same time, HP has also received a downgrade from Morgan Stanley. Interestingly, Hewlett-Packard Enterprise now owns companies rather than selling them off.
3. According to a report from the Financial Times, Tim Cook, Apple’s long-time CEO, might resign next year. John Tarnas, who is Apple’s senior vice president of hardware engineering, is being seen as a possible successor. In the meantime, Apple’s shares have dropped over 1% this morning.
4. Barclays analysts upgraded Gap from Hold to Buy, noting the retailer’s capability to handle tariff impacts and a solid performance during the back-to-school season. Additionally, they have a stake in TJX.
5. TD Cowen has also upgraded Yum Brands from Hold to Buy, increasing its price target from $162 to $173. They believe that selling off the struggling Pizza Hut could enhance the company’s growth outlook.
6. The club that holds Boeing has secured a $38 billion order for 777x planes from Emirates Airlines. This indicates a positive demand for U.S. aircraft manufacturers who have been facing struggles recently.
7. BMO Capital raised its price target on Palo Alto Networks from $225 to $230 just before quarterly results are announced. Analysts there continue to back the stock, emphasizing that cybersecurity remains a promising investment area. The club also holds shares in CrowdStrike.
8. Bank of America recently upped Snowflake’s price target from $280 to $310 in anticipation of earnings coming in early December, while also maintaining a buy rating on the stock.
9. Johnson & Johnson has revealed plans to acquire Hulda Therapeutics, a cancer drug developer, for $3.05 billion in cash. This move reflects a growing trend of mergers and acquisitions in the biotech sector. Earlier this year, they also bought Intracellular Therapeutics, a maker of nerve drugs, for $14.6 billion.
10. Novo Nordisk is set to reduce the price of its obesity drug for cash patients. While the adjusted prices will now be less than Eli Lilly’s, Novo Nordisk still offers superior products that could justify a premium price.
For more insights, you can sign up for the Top 10 Morning Thoughts on the Markets newsletter.
As a member of Jim Cramer’s CNBC Investment Club, you’ll receive trade alerts before any trades are made. After issuing a trade alert, Jim allows a 45-minute window before executing any buy or sell orders in his charitable trust’s portfolio. When discussing a stock on CNBC, he issues a trade alert and waits 72 hours before acting on it.
The details mentioned above regarding the investment club are subject to Terms of Use and Privacy Policy. It’s important to note that no fiduciary duties arise from the information provided, and specific results or benefits aren’t guaranteed.
